Clinical Trials Browser

Phase 4 × Recruiting × Carcinoma, Medullary × Clear all

NCT05830500 2023-07-25

Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma

Phase 4 Recruiting

Carcinoma, Medullary